2.5.5: Renin-angiotensin system drugs

Part of chapter 2 Cardiovascular System, section 2.5 Hypertension and heart failure

---

High-level prescribing trends for Renin-angiotensin system drugs (BNF section 2.5.5) across London Commissioning Region for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

Chemicals

Aliskiren (0205053A0)
Azilsartan medoxomil (0205052AD)
Candesartan cilexetil (0205052C0)
Captopril (0205051F0)
Cilazapril (0205051E0)
Co-zidocapt (Hydrochlorothiazide/captopril) (0205051G0)
Enalapril maleate (0205051I0)
Enalapril maleate with diuretic (0205051H0)
Eprosartan (0205052W0)
Fosinopril sodium (0205051J0)
Imidapril hydrochloride (0205051W0)
Irbesartan (0205052I0)
Irbesartan with diuretic (0205052A0)
Lisinopril (0205051L0)
Lisinopril with diuretic (0205051K0)
Losartan potassium (0205052N0)
Losartan potassium with diuretic (0205052P0)
Moexipril hydrochloride (0205051C0)
Olmesartan medoxomil (0205052B0)
Olmesartan medoxomil/amlodipine (0205052AB)
Olmesartan medoxomil/amlodipine/hydrochlorothiazide (0205052AC)
Olmesartan medoxomil/hydrochlorothiazide (0205052Y0)
Perindopril arginine (0205051Y0)
Perindopril arginine with diuretic (0205051Z0)
Perindopril erbumine (0205051M0)
Perindopril erbumine with diuretic (0205051N0)
Perindopril tosilate (0205051AA)
Perindopril tosilate/indapamide (0205051AB)
Perindopril with calcium channel blocker (0205051AC)
Quinapril hydrochloride (0205051Q0)
Quinapril hydrochloride with diuretic (0205051P0)
Ramipril (0205051R0)
Ramipril with calcium channel blocker (0205051S0)
Sacubitril/valsartan (0205052AE)
Telmisartan (0205052Q0)
Telmisartan with diuretic (0205052R0)
Trandolapril (0205051U0)
Trandolapril with calcium channel blocker (0205051V0)
Valsartan (0205052V0)
Valsartan with diuretic (0205052X0)